Trilipix Interactions
There are 80 drugs known to interact with Trilipix (fenofibric acid), along with 6 disease interactions. Of the total drug interactions, 19 are major, and 61 are moderate.
- View all 80 medications that may interact with Trilipix
- View Trilipix disease interactions (6)
Most frequently checked interactions
View interaction reports for Trilipix (fenofibric acid) and the medicines listed below.
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- carvedilol
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- hydrochlorothiazide
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- losartan
- Lovaza (omega-3 polyunsaturated fatty acids)
- Lyrica (pregabalin)
- metformin
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- Nexium (esomeprazole)
- omeprazole
- Plavix (clopidogrel)
- simvastatin
- Singulair (montelukast)
- Synthroid (levothyroxine)
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zetia (ezetimibe)
Trilipix disease interactions
There are 6 disease interactions with Trilipix (fenofibric acid) which include:
- biliary cirrhosis
- cholelithiasis
- liver disease
- renal dysfunction
- rhabdomyolysis
- hematological changes
Report options
QR code containing a link to this page
More about Trilipix (fenofibric acid)
- Trilipix consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (18)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: fibric acid derivatives
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
